https://www.selleckchem.com/TGF-beta.html
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Experimental Biology.BACKGROUND Improving cytomegalovirus (CMV) immune-risk stratification in kidney transplantation is highly needed to establish guided preventive strategies. METHODS This prospective, interventional, multicenter clinical trial assessed the value of monitoring pretransplant CMV-specific cell-mediated immunity (CMI) using an interferon-γ release assay to predict CMV infection in kidney transplantation. One hundred sixty donor/recipient CMV-s
Like
Comment
Share
